Search Results
Access to Covid-19 Vaccines, Medicines and Diagnostics: Voluntary & Compulsory Licenses TRIPS Waiver
COVID-19: European Commission supports simplified compulsory licensing rather than a TRIPS waiver
COVID19 Pandemic: Intellectual Property Management for Access to Diagnostics, Medicines and Vaccines
WEBINAR: 'Access Barriers to Covid-19 Therapeutics & Diagnostics: A Case for TRIPS Waiver'
Covid-19 Vaccines and Intellectual Property
PSN Seminar Series - Aisling McMahon, Patents, Access to Healthcare and Covid-19
The People’s Vaccine: IP, Access to Medicines, and the Coronavirus COVID-19 - Prof. Matthew Rimmer
The People's Vaccine: Intellectual Property and Access to Medicines in the Age of COVID-19
19/01/2021: Learning session on Access to Covid-19 vaccines and technologies
Waiving IP for Covid-19 related health products and technologies: prospects and solutions (23/06/21)
PEH SIG: Equitable Access to COVID-19 Vaccines
Discussion on the Proposed TRIPS Waiver for IP Rights Associated with COVID Vaccines and Treatments
